| Identification |
| Name: | 3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-6-hydroxyquinazoline-2,4(1H,3H)-dione |
| Synonyms: | 6-Hydroxyketanserin;AC1L3U0N;2,4(1H,3H)-Quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-6-hydroxy-;3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-6-hydroxy-1H-quinazoline-2,4-dione;( )-3-(2-(4-(4-Fluorobenzoyl)-1-piperidinyl)ethyl)-6-hydroxy-2,4(1H,3H)-quinazolinedione;115994-49-5;2,4(1H,3H)-Quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-6-hydroxy-, ( )-;94840-70-7 |
| CAS: | 115994-49-5;94840-70-7 |
| Molecular Formula: | C22H22FN3O4 |
| Molecular Weight: | 411.4262 |
| InChI: | InChI=1/C22H22FN3O4/c23-16-3-1-14(2-4-16)20(28)15-7-9-25(10-8-15)11-12-26-21(29)18-13-17(27)5-6-19(18)24-22(26)30/h1-6,13,15,27H,7-12H2,(H,24,30) |
| Molecular Structure: |
 |
| Properties |
| Density: | 1.339g/cm3 |
| Refractive index: | 1.609 |
| Safety Data |
| |
 |
